Commonwealth Serum Laboratories (Conversion into Public Company) Regulations

Administered by Department of Health, Disability and Ageing

Legislation au F1996B00278 Regulations Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

STATUTORY RULES 1990 No. 406

COMMONWEALTH SERUM LABORATORIES

(CONVERSION INTO PUBLIC COMPANY)

REGULATIONS

Section 45 of the Commonwealth Serum Laboratories Act 1961 (the Act) provides that the Governor-General may make Regulations for the purposes of the Act.

Under section 44C of the Act, the Commonwealth Serum Laboratories is required to apply to the National Companies and Securities Commission under subsection 85(1) of the Companies Act 1981 to be registered as a company.

The Regulations make provision for the application for registration as a company, and also for the lodgement of documents required under subsection 85(4) of the Companies Act 1981 which must accompany such an application. This provision is necessary due to the deeming mechanism used to establish the Commonwealth Serum Laboratories Commission as a company.

The Regulations will not come into force until subsection 44C(2) of the Act commences in accordance with subsection 2(3) or (4) of the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990.

Overview

The Commonwealth Serum Laboratories (Conversion into Public Company) Regulations 1996 were enacted to facilitate the transition of the Commonwealth Serum Laboratories from a statutory authority to a public company. This legislative instrument was introduced to address the procedural requirements for such a significant organisational change, ensuring compliance with corporate laws and regulations. The policy objective, as outlined in the explanatory statement, is to streamline the conversion process by providing a clear framework for the necessary applications and document submissions to the National Companies and Securities Commission, as mandated by the Commonwealth Serum Laboratories Act 1961 and the Companies Act 1981. The Regulations were enacted by the Parliament of Australia to ensure that the conversion process is orderly and legally compliant, ultimately facilitating the operational and administrative efficiency of the Commonwealth Serum Laboratories as a public company.

Scope and Application

The Commonwealth Serum Laboratories (Conversion into Public Company) Regulations, established under section 45 of the Commonwealth Serum Laboratories Act 1961, pertain specifically to the Commonwealth Serum Laboratories, which is mandated to transition from its current form into a public company. These regulations are designed to facilitate the application for registration as a company under the National Companies and Securities Commission as required by section 44C of the Act. They outline the procedural steps and documentation necessary for the application, ensuring compliance with subsection 85(1) of the Companies Act 1981, including the lodgement of specific documents stipulated in subsection 85(4) of that Act. The regulations will not be effective until the specified commencement date outlined in the Commonwealth Serum Laboratories (Conversion into Public Company) Act 1990. These provisions are critical to the proper functioning of the deemed mechanism established for the conversion of the Commonwealth Serum Laboratories Commission into a company, thereby ensuring a smooth transition and adherence to corporate governance standards.

Key Provisions

The key operative sections of the Commonwealth Serum Laboratories (Conversion into Public Company) Regulations are sections 3 and 4 (sections 3 and 4). Section 3 specifies the form of the application for registration as a company by the Commonwealth Serum Laboratories, ensuring that the application meets the requirements set out in the Companies Act 1981. Section 4 details the documents that must accompany this application, in accordance with subsection 85(4) of the Companies Act 1981. These provisions are essential to formalise the transition of the Commonwealth Serum Laboratories from a statutory body to a registered company, adhering to the legislative framework governing company registration. The Regulations impose specific obligations on the Commonwealth Serum Laboratories, primarily regarding the application for registration as a company. According to section 3, the application must be made to the National Companies and Securities Commission as required by subsection 85(1) of the Companies Act 1981. Section 4 further mandates the lodgement of the necessary documents specified under subsection 85(4) of the same Act. These obligations ensure that the transition is conducted in compliance with the regulatory requirements and that the Commonwealth Serum Laboratories is duly registered as a company. There are no explicit provisions in the Regulations regarding offences, penalties, or consequences for non-compliance. However, given that the Regulations are designed to facilitate the conversion of the Commonwealth Serum Laboratories into a public company in accordance with the overarching legislation, any failure to adhere to the stipulated requirements could potentially result in legal ramifications under the Companies Act 1981 or other relevant laws. The penalties for non-compliance with company registration requirements can include fines, disqualification from managing companies, or other civil or criminal sanctions as provided by the Companies Act 1981.

Legal classification tags

Area of Law
Corporate Law & Governance
Instrument
Regulation
Concepts
Commencement Provisions
Licensing & Registration
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.